Product Description: Abaloparatide (BA 058) is a parathyroid hormone receptor 1 (PTHR1) analog. Abaloparatide also is a selective PTHR1 activator. Abaloparatide enhances Gs/cAMP signaling and β-arrestin recruitment. Abaloparatide enhances bone formation and cortical structure in mice. Abaloparatide has the potential for the research of osteoporosis[1][2].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C174H300N56O49
References: [1]Sahbani K, et al. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide. Physiol Rep. 2019 Oct;7(19):e14225./[2]Varela A, et al. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption. J Bone Miner Res. 2017 Jan;32(1):24-33.
CAS Number: 247062-33-5
Molecular Weight: 3960.59
Compound Purity: 99.94
Research Area: Metabolic Disease
Solubility: DMSO : 25 mg/mL (ultrasonic)
Target: Arrestin;Thyroid Hormone Receptor